Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients

被引:30
作者
Bartosik-Psujek, H [1 ]
Stelmasiak, Z [1 ]
机构
[1] Med Univ Lublin, Dept Neurol, PL-20090 Lublin, Poland
关键词
multiple sclerosis; IL-4; IL-12; CCL2; CCL5;
D O I
10.1007/s00702-004-0225-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS). Both cytokines and chemokines have been implicated in the pathogenesis of MS. The aim of the study was to assess whether cytokine levels are correlated with chemokine levels during a different stage of relapsing-remitting MS (RR-MS). The study included 53 patients with RR-MS (20 subjects in stable stage and 18 patients with relapse). By ELISA method, the levels of the interleukin-4 (IL-4), interleukin-12 (IL-12), CCL2 and CCL-5 chemokines were measured both in serum and cerebrospinal fluid (CSF) of all patients. The serum IL-4 and IL-12 levels and CSF CCL5 level of patients with stable RR-MS were significantly different from the control level and the IL-12 levels were correlated with CCL5 levels in serum. During the relapse, a significant change in chemokine levels both in serum and CSF and IL-12 in CSF were noted, however no correlations were found between cytokines and chemokines.
引用
收藏
页码:797 / 803
页数:7
相关论文
共 19 条
[1]   Molecular pathogenesis of multiple sclerosis [J].
Bar-Or, A ;
Oliveira, EML ;
Anderson, DE ;
Hafler, DA .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :252-259
[2]   Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients [J].
Drulovic, J ;
MostaricaStojkovic, M ;
Levic, Z ;
Stojsavljevic, N ;
Pravica, V ;
Mesaros, S .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 147 (02) :145-150
[3]   Increased release of interleukin-12p40 in MS - Association with intracerebral inflammation [J].
Fassbender, K ;
Ragoschke, A ;
Rossol, S ;
Schwartz, A ;
Mielke, O ;
Paulig, A ;
Hennerici, M .
NEUROLOGY, 1998, 51 (03) :753-758
[4]   Interferon γ and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment [J].
Franciotta, D ;
Zardini, E ;
Bergamaschi, R ;
Andreoni, L ;
Cosi, V .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01) :123-126
[5]  
Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10
[6]   Balancing the Th1/Th2 concept in multiple sclerosis [J].
Laman, JD ;
Thompson, EJ ;
Kappos, L .
IMMUNOLOGY TODAY, 1998, 19 (11) :489-490
[7]  
Losana G, 2002, J LEUKOCYTE BIOL, V72, P735
[8]  
Mahad DJ, 2002, J NEUROL NEUROSUR PS, V72, P498
[9]   Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE [J].
Matejuk, A ;
Dwyer, J ;
Ito, A ;
Bruender, Z ;
Vandenbark, AA ;
Offner, H .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (05) :680-688
[10]   Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127